Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Forensic Genomics Market, by Application
1.4.2 Asia Pacific Forensic Genomics Market, by Product
1.4.3 Asia Pacific Forensic Genomics Market, by Method
1.4.4 Asia Pacific Forensic Genomics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. Asia Pacific Forensic Genomics Market by Application
4.1 Asia Pacific Criminal Testing Market by Country
4.2 Asia Pacific Paternity & Familial Testing Market by Country
4.3 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Forensic Genomics Market by Product
5.1 Asia Pacific Kits & Consumables Market by Country
5.2 Asia Pacific Analyzers & Sequencers Market by Country
5.3 Asia Pacific Software Market by Country
Chapter 6. Asia Pacific Forensic Genomics Market by Method
6.1 Asia Pacific Capillary Electrophoresis Market by Country
6.2 Asia Pacific Next-generation Sequencing Market by Country
6.3 Asia Pacific PCR Amplification Market by Country
Chapter 7. Asia Pacific Forensic Genomics Market by Country
7.1 China Forensic Genomics Market
7.1.1 China Forensic Genomics Market by Application
7.1.2 China Forensic Genomics Market by Product
7.1.3 China Forensic Genomics Market by Method
7.2 Japan Forensic Genomics Market
7.2.1 Japan Forensic Genomics Market by Application
7.2.2 Japan Forensic Genomics Market by Product
7.2.3 Japan Forensic Genomics Market by Method
7.3 India Forensic Genomics Market
7.3.1 India Forensic Genomics Market by Application
7.3.2 India Forensic Genomics Market by Product
7.3.3 India Forensic Genomics Market by Method
7.4 South Korea Forensic Genomics Market
7.4.1 South Korea Forensic Genomics Market by Application
7.4.2 South Korea Forensic Genomics Market by Product
7.4.3 South Korea Forensic Genomics Market by Method
7.5 Singapore Forensic Genomics Market
7.5.1 Singapore Forensic Genomics Market by Application
7.5.2 Singapore Forensic Genomics Market by Product
7.5.3 Singapore Forensic Genomics Market by Method
7.6 Malaysia Forensic Genomics Market
7.6.1 Malaysia Forensic Genomics Market by Application
7.6.2 Malaysia Forensic Genomics Market by Product
7.6.3 Malaysia Forensic Genomics Market by Method
7.7 Rest of Asia Pacific Forensic Genomics Market
7.7.1 Rest of Asia Pacific Forensic Genomics Market by Application
7.7.2 Rest of Asia Pacific Forensic Genomics Market by Product
7.7.3 Rest of Asia Pacific Forensic Genomics Market by Method
Chapter 8. Company Profiles
8.1 General Electric (GE) Co. (GE Healthcare)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Product Launches and Product Expansions:
8.2.5.3 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 Agilent Technologies, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Illumina, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 Neogen Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.6 Eurofins Scientific Group (Eurofins Discovery)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.7 Gene by Gene, Ltd.
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 Verogen, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.8.2.3 Acquisition and Mergers:
Unique Offerings 